Katrina Thornber, Author at European Medical Journal - Page 15 of 50

EuroPCR 2025: FFR-Guided PCI Lowers Complications After TAVI

Physiology-guided PCI halves major complications after TAVI compared to angiography alone, new FAITAVI trial data show.

EuroPCR 2025: Less Bleeding after PCI with Short DAPT and Prasugrel in Acute Coronary Syndrome

Shorter dual antiplatelet therapy followed by low-dose prasugrel cuts bleeding risk after PCI, new trial shows.

Side Effects in Bladder Cancer Treatment Worse Than Estimated

The analysis included patient-reported symptoms from treatment initiation to cycle 12 of pembrolizumab.

Cytisinicline Proves Potent and Safe for Quitting Smoking

A new Phase III trial has strengthened the evidence supporting cytisinicline as an effective and well-tolerated medication for smoking cessation.

Robotic Baby Mimics Real Feeding Behaviours for Medical Innovation

BabyBot, a soft robotic infant, mimics real feeding behaviours for safer, more realistic paediatric research and innovation.

Lanadelumab Reduces HAE Attacks in Adolescent Patients

The analysis demonstrated significant reductions in HAE attacks among adolescent patients.

Simultaneous Acne and Scar Treatment Proves More Effective

Beyond clinical outcomes, the simultaneous approach offered additional benefits: reduced overall treatment time and higher patient satisfaction.

Bariatric Surgery Improves Survival in Patients with Cirrhosis

Notably, the study found that bariatric surgery was cost-effective based on the incremental cost-effectiveness ratio.

Does Smoking Help with Ulcerative Colitis?

Smoking may reduce the risk of developing ulcerative colitis and alleviate disease severity in existing cases.

Emerging Resistance to Newest Antibiotic Ceftazidime/Avibactam

Ceftazidime/avibactam, a key antimicrobial against multidrug-resistant Gram-negative pathogens, has seen increasing use across England since its 2017 launch.